Evidence map›Paper›PMID 32188779›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Metabolic control analysis of hepatic glycogen synthesis in vivo.

Yuichi Nozaki, Max C Petersen, Dongyan Zhang, Daniel F Vatner, Rachel J Perry, Abudukadier Abulizi, Sofie Haedersdal, Xian-Man Zhang, Gina M Butrico, Varman T Samuel and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Admixture Mapping of Lipid Traits in Hispanic Americans.Journal of the American Heart Association · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome.International journal of molecular sciences · 2023
    Review
  19. Article
  20. The Liver and Glycogen: In Sickness and in Health.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Yuichi NozakiDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.ORCID 0000-0003-2881-675X
Max C PetersenDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.
Dongyan ZhangDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.
Daniel F VatnerDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.ORCID 0000-0003-2073-0273
Rachel J PerryDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.
Abudukadier AbuliziDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.
Sofie HaedersdalDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.
Xian-Man ZhangDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.
Gina M ButricoDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.
Varman T SamuelDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.
Graeme F MasonDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06520.
Gary W ClineDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.
Kitt F PetersenDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.ORCID 0000-0003-2664-670X
Douglas L RothmanCenter for Clinical Metabolic Research, Gentofte and Herlev Hospital, 2900 Hellerup, Denmark.
Gerald I ShulmanDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520; gerald.shulman@yale.edu.
Yale University · USHerlev Hospital · DKSteno Diabetes Centers · DKVeterans Health Administration · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI MICHAEL H NATHANSON, Mario Strazzabosco · 1986 to 2026
$31.1M
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin ResistanceR01DK113984 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2017 to 2021
$3.7M
Brain Acetate and Ethanol Metabolism in Alcohol Dependence and AbuseR01AA021984 · NIAAA · YALE UNIVERSITY · PI MASON, GRAEME F. · 2013 to 2017
$2.7M
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human PrimatesR01DK119968 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2019 to 2024
$2.7M
Microbiome origins and insulin regulatory responses of the short chain fatty acid acetateR01DK114793 · NIDDK · YALE UNIVERSITY · PI GOODMAN, ANDREW L, SHULMAN, GERALD I · 2018 to 2021
$2.4M
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue MetabolismR01DK108283 · NIDDK · YALE UNIVERSITY · PI KIBBEY, RICHARD G, MASON, GRAEME F. · 2016 to 2019
$2.1M
Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1R01DK116774 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2018 to 2021
$1.7M
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS R01 AA021984NIDDK NIH HHS P30 DK034989NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK108283NIDDK NIH HHS R01 DK113984NIDDK NIH HHS R01 DK114793NIDDK NIH HHS R01 DK116774NIDDK NIH HHS R01 DK119968
6 · The paper itself

Abstract

Multiple insulin-regulated enzymes participate in hepatic glycogen synthesis, and the rate-controlling step responsible for insulin stimulation of glycogen synthesis is unknown. We demonstrate that glucokinase (GCK)-mediated glucose phosphorylation is the rate-controlling step in insulin-stimulated hepatic glycogen synthesis in vivo, by use of the somatostatin pancreatic clamp technique using [

Indexed as

AnimalsDiet, High-FatDisease Models, AnimalFatty LiverGene Knockdown TechniquesGlucokinaseGlucoseGlucose-6-PhosphateHumansHyperglycemiaHyperinsulinismInsulinInsulin ResistanceLiverLiver GlycogenMaleGlucokinaseGlucoseGlucose-6-PhosphateInsulinLiver Glycogenglucokinasehepatic glycogen synthesishepatic insulin resistancein vivometabolic control analysis

Identifiers

PMID32188779
PMCPMC7149488
OpenAlexW3011907612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.